4:46 PM
 | 
May 16, 2018
 |  BC Extra  |  Politics & Policy

CMS initiates national coverage analysis of CAR T therapies

CMS began a national coverage analysis Wednesday to review the use of CAR T cell therapies to treat cancer.

An NCA is the first step in the path to developing a National Coverage Decision that would impose a uniform national coverage policy. In February, UnitedHealth Group Inc. (NYSE:UNH) requested...

Read the full 229 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >